Zesban Muhammedi

Co-founder & Managing Partner

2020 - Current

Venture capital for environmental health and healthcare infrastructure startups tackling the root causes of why we get sick. Learn more at mbxcapital.com

Member, Board of Directors

2023

Macro Trials is the precision research clinical platform, driving increased research velocity and an amplified patient experience to unlock value for all stakeholders in the clinical trial ecosystem. Via its digitally powered infrastructure and "hub-and-spoke" distributed model, Macro partners with pharmaceutical companies, CROs, providers, and health systems to conduct trials for high-value therapeutics. The company’s turnkey platform empowers physicians to participate in groundbreaking research via workflow-native efficiency tools, clinical research personnel and a network of logistic partners. Macro’s clinical trial intelligence platform and proprietary real-world evidence as a service (RWEaaS) product supports life sciences companies in all aspects of therapeutic research, development, and commercialization.

Kauffman Fellow | Class 25

2020

Advisor

2019

Advisor to BrainMind, a consortium working to support advances in brain science in collaboration with leading scientists at Stanford, MIT, and Harvard.

Member, Board of Directors

2020 - 2024

SecureAire is a leading pathogen detection and active air filtration platform for improving indoor air quality. Their platform is a leader in reducing healthcare facility acquired infections and is expanding into commercial, residential, and industrial real estate markets.

Member, Board of Directors

2021 - 2024

Attivare Therapeutics is using its novel biomaterial-based platform technology to vaccinate against oncology indications and infectious diseases. Our goal is to provide effective prophylactic and therapeutic treatments for a variety of unmet medical needs. Formerly known as Omnivax, Attivare spun out of Dr. Dave Mooney's lab at Harvard's Wyss Institute.

Member, Board of Directors (Observer)

2021 - 2023

Mae is a culturally competent maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.

Member Board of Directors

2020 - 2023

CloudCath is a digital health medical device company that is dedicated to remote complication monitoring for patients undergoing catheter-based treatments. Became an Observer to Board in March 2023.

Co-Founder, CEO

2015 - 2020

Healthcare investment and research marketplace. Fund business spun out as MBX Capital in July 2020.

Managing Partner

2010 - 2015